Maharishi International University

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Maharishi International University sits in the upper quartile of US sponsors by registered trial count (#1,604 of 15,742 sponsors by registered trial count).

8 total trials 2 currently recruiting 5 completed early-phase tilt upper quartile by trial count

Maharishi International University: 8 sponsored US clinical trials, 2 recruiting.

Maharishi International University sponsors 8 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 5 completed. 0 of these trials are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Migraine With or Without Aura, with 1 trials.

Upper-quartile sponsor footprint

Maharishi International University sits in the upper quartile of the sponsor corpus (#1,604 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Open and recent trials

8 total, page 1 of 1

RECRUITING NA

Effects of Binaural Beats and Spatialized Music on Behavioural and Psychological Symptoms of Dementia in Assisted Living Facility Residents

NCT07626944
RECRUITING

Brain-to-brain Synchrony in Ss With Different Levels of Social Interaction

NCT06673589
ACTIVE NOT RECRUITING NA

Exploring the Effect of the Transcendental Meditation® Technique on Migraine Frequency and Functionality: A Single Arm Study

NCT06695156
COMPLETED NA

Ayurveda Diet & Lifestyle Protocol for Type 2 Diabetes: A Feasibility Study

NCT07400276
COMPLETED NA

Evaluating Mechanisms of Blood Pressure Reduction Using Meditation in Hypertensive African Americans

NCT00681200
COMPLETED Phase 2

A Clinical Trial of the Transcendental Meditation (TM) Program on Blood Pressure, Psychological Distress, and Coping

NCT00924456
COMPLETED NA

Evaluation of an Ayurvedic Herbal Compound Compared to Vitamins C+E and Placebo on Vascular Function in High-Risk Subjects

NCT07206901
COMPLETED Phase 2

A Randomized Controlled Trial of Stress Reduction on Cardiovascular Morbidity and Mortality in African Americans

NCT01299935

Phase Distribution

PhaseTrial count
Phase 2 2

Therapeutic Areas

Migraine With or Without Aura 1
Social Dynamics 1
Migraine 1

What is open in the Maharishi International University pipeline

2 recruiting of 8 indexed (25% open); 5 completed (63%).

Phase mix: 0 late (III/IV) vs 2 early (I/II) (early-phase heavy).

Top condition: Migraine With or Without Aura (1 trial), 2 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Maharishi International University: open-pipeline peers nationwide

Peers matched on 8 registered trials and 25% open enrollment, not the therapeutic-area sidebar.

Maharishi International University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 3456789 0%10%20%30%40% Total trials Recruiting share Maharishi International UniversityAB ScienceAbbott Point of CareAbeona TherapeuticsAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Abdul Latif Jameel Poverty Action LabAccutar BiotechnologyAdrienne G. WaksAdvocate Hospital System
Maharishi International University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Maharishi International University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 8 trials (± recruiting share)

Sponsors near 25% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Maharishi International University page

8 registered trials is a research-attention snapshot, not an endorsement of Maharishi International University or any single study.

  • 2 of Maharishi International University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Migraine With or Without Aura is the condition Maharishi International University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Migraine With or Without Aura trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Maharishi International University pipeline card: 8 registered trials from official public datasets.Report a data error.